{"id":"W2111877246","doi":"10.1111/nyas.12180","title":"Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma","year":2013,"lang":"en","type":"review","venue":"Annals of the New York Academy of Sciences","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pyrogenesis (Canada)","funders":"National Cancer Institute","keywords":"Ipilimumab; Medicine; Melanoma; Oncology; Internal medicine; Clinical trial; Adverse effect; Immunotherapy; Cancer; Immunology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003480826,0.0003879006,0.0001859321,0.000528669,0.0001597691,0.000407978,0.000344056,0.0004980991,0.00268935],"category_scores_gemma":[0.0001419355,0.0001141354,0.0003027739,0.000207455,0.0003160883,0.0003652446,0.0002993097,0.001273925,0.0009758343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004312451,"about_ca_system_score_gemma":0.0004836462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004355679,"about_ca_topic_score_gemma":0.0007430175,"domain_scores_codex":[0.9999236,0.00001301524,0.000004650929,0.00001794248,0.00002423422,0.0000166213],"domain_scores_gemma":[0.9999493,0.00000520234,0.00001067109,0.000004038439,0.000009184545,0.00002146998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005789712,0.0006034236,0.0009171972,0.0007484581,0.00004461397,0.0007781502,0.00008207096,0.0006303588,0.2117455,0.00580624,0.01864297,0.759422],"study_design_scores_gemma":[0.00125408,0.004998998,0.01145413,0.0002594046,0.0001545731,0.007004826,0.00003490375,0.003988313,0.1327994,0.002817157,0.8351892,0.00004497174],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2437437,0.5932351,0.0536267,0.02380864,0.004681555,0.0008049274,0.0009343254,0.001503638,0.0776614],"genre_scores_gemma":[0.5726187,0.3286733,0.03575243,0.01004692,0.00337549,0.0005359107,0.001307674,0.0001331229,0.04755652],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00268935,"threshold_uncertainty_score":0.008996785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2503677468678624,"score_gpt":0.4109727332237618,"score_spread":0.1606049863558994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}